###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
CD209 Genetic Polymorphism and Tuberculosis Disease
###end article-title 0
###begin p 1
Conceived and designed the experiments: PF SC CK FV AH CL KT. Performed the experiments: FV. Analyzed the data: FV SF. Contributed reagents/materials/analysis tools: GS KM PF PA FV AH DJ SF AC CL LS BB PG OB. Wrote the paper: FV.
###end p 1
###begin p 2
Current address: Section for Genetic Medicine, Centre for Molecular Medicine, Agency for Science Technology and Research, Singapore, Singapore
###end p 2
###begin p 3
Current address: AstraZeneca, Macclesfield, Cheshire, United Kingdom
###end p 3
###begin title 4
Background
###end title 4
###begin p 5
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 179 205 179 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 479 484 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 179 205 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 366 371 <span type="species:ncbi:9606">human</span>
###xml 398 403 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 424 430 <span type="species:ncbi:9606">humans</span>
Tuberculosis causes significant morbidity and mortality worldwide, especially in sub-Saharan Africa. DC-SIGN, encoded by CD209, is a receptor capable of binding and internalizing Mycobacterium tuberculosis. Previous studies have reported that the CD209 promoter single nucleotide polymorphism (SNP)-336A/G exerts an effect on CD209 expression and is associated with human susceptibility to dengue, HIV-1 and tuberculosis in humans. The present study investigates the role of the CD209 -336A/G variant in susceptibility to tuberculosis in a large sample of individuals from sub-Saharan Africa.
###end p 5
###begin title 6
Methods and Findings
###end title 6
###begin p 7
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 358 359 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 368 369 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 583 584 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 594 595 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 433 441 <span type="species:ncbi:9606">patients</span>
A total of 2,176 individuals enrolled in tuberculosis case-control studies from four sub-Saharan Africa countries were genotyped for the CD209 -336A/G SNP (rs4804803). Significant overall protection against pulmonary tuberculosis was observed with the -336G allele when the study groups were combined (n = 914 controls vs. 1262 cases, Mantel-Haenszel 2x2 chi2 = 7.47, P = 0.006, odds ratio = 0.86, 95%CI 0.77-0.96). In addition, the patients with -336GG were associated with a decreased risk of cavitory tuberculosis, a severe form of tuberculosis disease (n = 557, Pearson's 2x2 chi2 = 17.34, P = 0.00003, odds ratio = 0.42, 95%CI 0.27-0.65). This direction of association is opposite to a previously observed result in a smaller study of susceptibility to tuberculosis in a South African Coloured population, but entirely in keeping with the previously observed protective effect of the -336G allele.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 280 288 280 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 372 377 372 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
This study finds that the CD209 -336G variant allele is associated with significant protection against tuberculosis in individuals from sub-Saharan Africa and, furthermore, cases with -336GG were significantly less likely to develop tuberculosis-induced lung cavitation. Previous in vitro work demonstrated that the promoter variant -336G allele causes down-regulation of CD209 mRNA expression. Our present work suggests that decreased levels of the DC-SIGN receptor may therefore be protective against both clinical tuberculosis in general and cavitory tuberculosis disease in particular. This is consistent with evidence that Mycobacteria can utilize DC-SIGN binding to suppress the protective pro-inflammatory immune response.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 143 158 143 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 270 273 270 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-1">[1]</xref>
###xml 376 391 376 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 484 487 484 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Frieden1">[2]</xref>
###xml 489 492 489 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Flynn1">[3]</xref>
###xml 601 604 601 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Frieden1">[2]</xref>
###xml 706 709 706 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Cooke1">[4]</xref>
###xml 881 884 881 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Comstock1">[5]</xref>
###xml 1014 1017 1014 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Stead1">[6]</xref>
###xml 1159 1162 1159 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Doffinger1">[7]</xref>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 143 158 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 231 238 <span type="species:ncbi:9606">persons</span>
###xml 337 343 <span type="species:ncbi:9606">people</span>
###xml 376 391 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1152 1158 <span type="species:ncbi:9606">humans</span>
Mycobacterium tuberculosis infection causes significant morbidity and mortality throughout the world, particularly in resource-poor countries. M. tuberculosis infects one third of the human population and approximately two million persons die of tuberculosis every year [1]. Over the next 20 years the WHO estimates that another billion people will become newly infected with M. tuberculosis and more than 25 million will die from the disease, despite the availability of antibiotics [2], [3]. In sub-Saharan Africa, the rates of tuberculosis range from 50 to greater than 300 per 100,000 individuals [2]. It is now well-established that there is a host genetic component to susceptibility to tuberculosis [4]. Evidence to support this includes the observation of familial clustering of disease with higher concordance of tuberculosis disease in monozygotic versus dizygotic twins [5], the ethnic clustering of tuberculosis disease with a higher prevalence of tuberculosis in individuals of recent African descent [6], as well as the demonstration of both common polymorphisms and rare mutations which confer susceptibility to mycobacterial species in humans [7].
###end p 11
###begin p 12
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 201 204 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Soilleux1">[8]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Tailleux2">[10]</xref>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Gordon1">[11]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Gordon1">[11]</xref>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-vanKooyk1">[15]</xref>
###xml 502 517 502 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 519 528 519 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 530 554 530 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus Calmette-Gu&#233;rin</italic>
###xml 562 580 562 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Heliobacter pylori</italic>
###xml 582 606 582 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 608 629 608 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Klebsiella pneumoniae</italic>
###xml 715 734 715 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 736 754 736 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania pifanoi</italic>
###xml 759 775 759 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 775 779 775 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Tailleux2">[10]</xref>
###xml 781 785 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Alvarez1">[16]</xref>
###xml 786 790 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Tassaneetrithep1">[28]</xref>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-vanKooyk2">[29]</xref>
###xml 387 390 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 502 517 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 519 528 <span type="species:ncbi:1769">M. leprae</span>
###xml 530 554 <span type="species:ncbi:33892">Bacillus Calmette-Guerin</span>
###xml 582 606 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 608 629 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 631 636 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 638 643 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 645 648 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 652 664 <span type="species:ncbi:12637">Dengue virus</span>
###xml 696 713 <span type="species:ncbi:11103">Hepatitis C virus</span>
###xml 715 734 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 736 754 <span type="species:ncbi:5682">Leishmania pifanoi</span>
###xml 759 775 <span type="species:ncbi:5476">Candida albicans</span>
Dendritic Cell-Specific ICAM3-Grabbing Non-integrin (DC-SIGN), encoded by CD209 on chromosome 19p13.3, is a C-type lectin that is expressed on subsets of dendritic cells (DCs) and alveolar macrophages [8]-[10]. DC-SIGN has been demonstrated to bind a variety of ligands [11]; endogenous ligands include endothelial cells through ICAM-2, T-lymphocytes through ICAM-3, neutrophils through MAC-1 and various endogenous glycosylated structures [11]-[15]; exogenous ligands include glycosylated moieties on M. tuberculosis, M. leprae, Bacillus Calmette-Guerin (BCG), Heliobacter pylori, Streptococcus pneumoniae, Klebsiella pneumoniae, HIV-1, HIV-2, SIV-1, Dengue virus, Ebola Virus, Cytomegalovirus, Hepatitis C virus, Schistosoma mansoni, Leishmania pifanoi and Candida albicans[10], [16]-[28] (and reviewed in [29]).
###end p 12
###begin p 13
###xml 32 47 32 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 187 205 187 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium spp.</italic>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Geijtenbeek2">[13]</xref>
###xml 255 270 255 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Geijtenbeek4">[22]</xref>
###xml 497 512 497 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Geijtenbeek4">[22]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-vanKooyk2">[29]</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-vanKooyk2">[29]</xref>
###xml 32 47 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 255 270 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 497 512 <span type="species:ncbi:1773">M. tuberculosis</span>
DC-SIGN is a major receptor for M. tuberculosis on immune cell subsets and has been shown to bind mannosylated lipoarabomannan (ManLAM) present on virulent, but not avirulent, strains of Mycobacterium spp.[13]. This binding can lead to internalization of M. tuberculosis and infection of DCs and alveolar macrophages [22]. DC-SIGN may also have additional roles in suppressing Toll-like receptor (TLR) signaling, thereby influencing Th1/Th2 balance (proinflammatory/anti-inflammatory) and causing M. tuberculosis-induced immune suppression [22], [29]. This effect is mediated by ManLAM and increased secretion of ManLAM from Mycobacteria may be crucial to tuberculosis disease progression [29].
###end p 13
###begin p 14
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 132 147 132 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 152 162 152 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae,</italic>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Barreiro1">[18]</xref>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Barreiro2">[30]</xref>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Sakuntabhai1">[32]</xref>
###xml 210 219 210 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Martin1">[31]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Sakuntabhai1">[32]</xref>
###xml 913 917 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Barreiro1">[18]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Barreiro2">[30]</xref>
###xml 938 943 938 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 132 147 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 152 161 <span type="species:ncbi:1769">M. leprae</span>
###xml 163 168 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 210 219 <span type="species:ncbi:1769">M. leprae</span>
###xml 470 475 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
There has been considerable recent interest in the role of CD209 variation in human susceptibility to infectious diseases including M. tuberculosis and M. leprae, HIV-1, and Dengue [18], [30]-[32]. All but the M. leprae case-control study found an association of the CD209 -336A/G promoter SNP with infectious disease susceptibility or protection. Martin and colleagues demonstrated that the -336G allele was associated with susceptibility to parenteral but not mucosal HIV-1 infection, although this was not replicated in individuals of recent African descent [31]. Sakuntabhai and colleagues found that the -336G allele was protective against Dengue fever versus Dengue hemorrhagic fever, but not against controls [32]. Barreiro and colleagues found an association between with the -871G and -336A alleles and protection against tuberculosis in South African Cape Coloureds, but not against leprosy in Pakistan [18], [30]. Although the CD209 -871 SNP was found to be the polymorphism most significantly associated with tuberculosis susceptibility in the South African Cape Coloureds, Barreiro and colleagues found that this SNP is not polymorphic in other African countries. The relatively high prevalence of the -871 SNP in the South African Cape Coloureds cases and controls is due to their inherent admixture with European and Asian populations.
###end p 14
###begin p 15
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 207 215 207 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Sakuntabhai1">[32]</xref>
###xml 300 315 300 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 458 463 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 300 315 <span type="species:ncbi:1773">M. tuberculosis</span>
Sakuntabhai and colleagues also presented evidence that the CD209 -336G allele disrupts a potential SP-1-like transcription factor binding site and that this allele is associated with lower CD209 expression in vitro than the ancestral -336A variant [32]. On the basis of the importance of DC-SIGN in M. tuberculosis binding and signaling events, and in an attempt to replicate the findings of Barreiro and colleagues in a larger population, we genotyped the CD209 -336A/G SNP in five tuberculosis case-control studies from four different sub-Saharan African countries.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Sample Information
###end title 17
###begin p 18
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Bennett1">[33]</xref>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Bellamy1">[34]</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Fitness1">[35]</xref>
###xml 266 281 266 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 266 281 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 326 331 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 386 391 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 712 717 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 801 806 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 864 871 <span type="species:ncbi:9606">persons</span>
The tuberculosis case control studies from The Gambia (A), Republic of Guinea and Guinea Bissau [33], The Gambia (B) [34], and Malawi [35] have been previously described in detail. Briefly, tuberculosis case definitions for all studies depended upon confirmation of M. tuberculosis positivity by culture, smear, or histology. HIV-1 testing was routinely performed and the percentage of HIV-1 positive individuals among the tuberculosis index cases and controls for the various studies are as follows: The Gambia (A), cases 7.5%, controls 5.2%; Republic of Guinea, cases 9.0%, controls 5.1%; Guinea Bissau, cases 23.8%, controls 16.2%; Malawi, cases 62.2%, controls 33.5%. The Gambia (B) cohort has 330 confirmed HIV-1 negative tuberculosis cases, with an additional 17 cases which were not tested for HIV-1 status. Controls for the various studies were defined as persons without a previous history of tuberculosis and were frequency matched for age, sex and area of residence. A number of clinical correlates of tuberculosis were recorded for the The Gambia (A), Republic of Guinea and Guinea Bissau studies including haemoptysis, duration of cough, degree of sputum positivity, and the presence of cavitation and number of zones affected on chest radiograph. Cavitory tuberculosis status and number of zones affected was determined by radiological analysis by board-certified radiologists.
###end p 18
###begin p 19
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 300 305 <span type="species:ncbi:9606">Human</span>
Informed written consent was obtained from patients or their parents or guardians. Ethical approval was provided by the joint Gambian Government/MRC Ethical Committee, Ministry of Public Health (MINSAP, Guinea-Bissau) and National Ethics Committee, Ministry of Health, Conakry, Republique de Guinee. Human experimentation guidelines of these ministries were followed. Ethical approval for the Malawi study protocol was obtained from the National Health Sciences Research Committee of Malawi and the London School of Hygiene and Tropical Medicine Ethics Committee.
###end p 19
###begin title 20
Genotyping techniques
###end title 20
###begin p 21
###xml 379 383 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Storm1">[36]</xref>
###xml 779 784 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 920 925 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 939 969 921 951 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACGTTGGATGCTCTGTCTGGGTCCTTTTAC</named-content>
###xml 971 1001 953 983 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACGTTGGATGACAGCAATGAAAAAGCAAAG</named-content>
###xml 1003 1028 985 1010 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCAAAGTACTAGTACATTTAATAAC</named-content>
###xml 1037 1042 1019 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 1056 1086 1038 1068 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACGTTGGATGTGTTACACCCCCTCCACTAG</named-content>
###xml 1088 1118 1070 1100 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACGTTGGATGAAAGCAGGAAAGCCAGGAGG</named-content>
###xml 1120 1140 1102 1122 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCCTCCACTAGGGCAAGGGT</named-content>
DNA extraction from blood was performed using Nucleon II kits (Scotlab Bioscience, Buckingham, UK). DNA concentrations were determined using the PicoGreentrade mark kit (Invitrogen, Carlsbad, USA). Genotyping was performed utilizing the Sequenomtrade mark system (Sequenom, San Diego, USA) which uses mass spectrometry (MALDI-TOF) to discriminate products by their absolute mass [36]. Primer extension was carried out utilizing a DNA primer adjacent to the SNP, and a specific reaction mix of polymerase, dNTPs and one ddNTPs. The extension products were then cleaned up to remove salts and 15nl were spotted onto a 384 SpectroCHIP (Sequenom). This chip was analysed by MALDI-TOF mass spectrometer and the alleles called by weight (in kilodaltons) of the extension products. The CD209 -871A/G (rs735239) and -336A/G (rs4804803) SNP assays were designed using the SPECTRODESIGNER software (Sequenom). The primers for the CD209 -871A/G were ACGTTGGATGCTCTGTCTGGGTCCTTTTAC, ACGTTGGATGACAGCAATGAAAAAGCAAAG, GCAAAGTACTAGTACATTTAATAAC and for CD209 -336A/G were ACGTTGGATGTGTTACACCCCCTCCACTAG, ACGTTGGATGAAAGCAGGAAAGCCAGGAGG, CCCTCCACTAGGGCAAGGGT. The assays were in 384-well plates containing 10 ng of DNA in each well were amplified by a touch-down PCR using Titanium Taq polymerase (Clontech). The touch-down PCR cycling conditions were as follows: 95degreesC for 15 minutes; 94degreesC for 20 seconds; 65degreesC for 30 seconds; 72degreesC for 30 seconds; steps 2 to 4 repeated for 5 cycles; 94degreesC for 20 seconds; 58degreesC for 30 seconds; 72degreesC for 30 seconds; steps 5 to 7 repeated for 5 cycles; 94degreesC for 20 seconds; 53degreesC for 30 seconds; 72degreesC for 30 seconds; steps 8 to 10 repeated for 38 cycles; final extension at 72degreesC for 3 minutes.
###end p 21
###begin title 22
Statistical analysis
###end title 22
###begin p 23
###xml 285 286 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1010 1011 1010 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 461 464 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Statistical analysis of genotype associations and logistic regression was performed using the program SPSS v14.0. The genotypic and allelic tests of association utilized Pearson's chi-square test with the respective degrees of freedom. All statistics are two-tailed. If the unadjusted P value was significant then further analysis was carried out using a stepwise forward binary logistic regression correction to adjust for the potential confounding factors of HIV status, age, ethnicity, and sex. Mantel-Haenszel for the combined analysis was performed using SPSS by weighting cases by frequency and stratifying by population. The Gambian (B) study utilizes the Gambian (A) study controls for this Mantel-Haenszel analysis. The Breslow-Day and Tarone's tests for homogeneity of odds ratios were found to be non-significant indicating that the odds ratio for each study did not significantly deviate from the overall, combined odds ratio. All control genotype distributions were in Hardy-Weinberg equilibrium (P>0.20).
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
CD209 and association with tuberculosis
###end title 25
###begin p 26
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Bennett1">[33]</xref>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 268 269 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Barreiro2">[30]</xref>
###xml 692 693 690 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 702 703 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 714 721 712 719 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 714 721 712 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001388-t001"><bold>Table 1</bold></xref>
###xml 850 851 848 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 899 906 897 904 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 899 906 897 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001388-t002"><bold>Table 2</bold></xref>
###xml 1291 1295 1289 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Bellamy1">[34]</xref>
###xml 971 976 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The CD209 -871A/G and -336A/G SNPs were initially genotyped in 329 tuberculosis cases and 327 control individuals from The Gambia (study group A) [33]. The CD209 -871 SNP was found to be polymorphic with controls and cases both having a 2.3% allele frequency (allelic P = 0.98) consistent with the Barreiro result [30] and the HapMap project which found variation at this SNP to be very rare to absent in individuals of African descent. The allelic equivalence between cases and controls and the rarity of this SNP precluded genotyping in further populations. For the CD209 -336A/G SNP, however, an overall genotypic association with clinical tuberculosis was observed for this cohort (3x2chi2 = 7.79, P = 0.020) (Table 1). The -336G allele was significantly under-represented in tuberculosis cases (47.0%) when compared to healthy controls (54.0%) (P = 0.010, odds ratio of 0.75 (95%CI 0.61-0.94) (Table 2). Logistic regression correction for age, sex, ethnic group and HIV-1 status did not significantly affect this association. Subsequently an additional 347 tuberculosis cases from The Gambia were available for genotyping (study group B), revealing a similar tuberculosis case allele frequency (48.0%) and a significant association when analyzed against the study group A control group [34].
###end p 26
###begin title 27
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 21 29 <span type="species:ncbi:9606">Patients</span>
CD209 -336A/G SNP in Patients Enrolled in Tuberculosis Case Control Studies in Four Countries
###end title 27
###begin p 28
###xml 54 55 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 83 88 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 315 316 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Genotypic frequency and genotypic association (3x2 chi2, 2 degrees of freedom) for CD209 -336A/G (rs4804803) from 2176 individuals enrolled in tuberculosis case control studies from The Gambia (A), Republic of Guinea and Guinea-Bissau (ref. 33), The Gambia (B) (ref. 34) and Malawi (ref. 35). Significance level of P<0.05 is indicated in bold.
###end p 28
###begin title 29
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
CD209 -336A/G SNP Allelic Association in Tuberculosis Case Control Studies
###end title 29
###begin p 30
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The allelic P value for 2176 individuals enrolled in tuberculosis case control studies. The Gambia (A), Republic of Guinea and Guinea-Bissau (ref. 33), The Gambia (B) (ref. 34) and Malawi (ref. 35). *The Gambia (B) study utilizes The Gambia (A) controls. Significance levels of P<0.05 are indicated in bold.
###end p 30
###begin p 31
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Bennett1">[33]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Lienhardt1">[37]</xref>
###xml 487 488 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 498 505 498 505 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 498 505 498 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001388-t002"><bold>Table 2</bold></xref>
###xml 635 636 635 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Study groups from Republic of Guinea, Guinea-Bissau, and Malawi were then used in an attempt to replicate this finding [33], [37]. Each study group, with the exception of Republic of Guinea study, demonstrated the same trend towards a protective effect of the -336G allele. In total 2176 individuals were analyzed in this study and combining the results in a Mantel-Haenszel test predicted a protective effect of the -336G allele with an overall odds ratio of 0.86 (95%CI 0.77-0.96) and P = 0.006 (Table 2). This allelic model yielded a non-significant homogeneity of odds ratio between all the study groups, (Tarone's and Breslow-Day P = 0.32), suggesting that there was a good consistency between the combined odds ratio with the individual odds ratios for each study.
###end p 31
###begin p 32
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 226 234 226 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S1</bold>
###xml 226 234 226 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001388.s001"><bold>Table S1</bold></xref>
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 150 153 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 264 267 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Considering that HIV-1 status could potentially confound this association we performed the Mantel-Haenszel test excluding all individuals known to be HIV positive, giving an odds ratio of 0.83 (95%CI 0.73-0.94) and P = 0.003 (Table S1). Although this exclusion of HIV-infected individuals reduces the total sample size of the study the conclusion remains unchanged.
###end p 32
###begin title 33
CD209 and clinical correlates of tuberculosis
###end title 33
###begin p 34
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 569 570 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 580 581 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 629 630 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 630 650 628 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bonferroni corrected</sub>
###xml 660 662 658 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 664 672 662 670 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 664 672 662 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001388-g001"><bold>Figure 1</bold></xref>
###xml 677 684 675 682 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 677 684 675 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001388-t003"><bold>Table 3</bold></xref>
###xml 158 161 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 405 413 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">Patients</span>
The CD209 -336A/G SNP was further examined in the cases for association with clinical correlates of tuberculosis, with no significant difference between sex, HIV status, age, haemoptysis, number of zones affected on chest radiograph, duration of cough or degree of sputum positivity. However, a significant association was obtained between CD209 -336GG genotype status and lung cavitation in tuberculosis patients. Patients homozygous for the CD209 -336GG allele were associated with 2.4-fold protection against cavitory tuberculosis disease (n = 557, Pearson's 2x2 chi2 = 17.34, P = 0.00003, odds ratio = 0.42, 95%CI 0.27-0.65, PBonferroni corrected = 1.19x10-4)(Figure 1 and Table 3).
###end p 34
###begin title 35
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 17 32 17 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 17 32 <span type="species:ncbi:1773">M. tuberculosis</span>
CD209 -336GG and M. tuberculosis-induced lung cavitation.
###end title 35
###begin p 36
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
This figure describes the percent of individuals with the CD209 -336GG genotype who presented with cavitory tuberculosis disease.
###end p 36
###begin title 37
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
CD209 -336A/G and Clinical Correlates of Tuberculosis
###end title 37
###begin p 38
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Combined West African tuberculosis case control data. Significance level of P<0.05 is indicated in bold.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 139 154 139 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 139 154 <span type="species:ncbi:1773">M. tuberculosis</span>
There is increasing evidence to support an important role for DC-SIGN in the pathophysiology of a number of infectious diseases, including M. tuberculosis infection.
###end p 40
###begin p 41
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Sakuntabhai1">[32]</xref>
###xml 161 169 161 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 185 198 185 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo CD209</italic>
Functional evidence suggests that the -336G variant has lower basal expression of CD209 when compared to the -336A ancestral allele [32]. Extrapolation of these in vitro experiments to in vivo CD209 expression suggests that -336G individuals would have lower levels of DC-SIGN on DCs and alveolar macrophages when compared to -336A individuals. Barreiro and colleagues found an association with the -336A allele and protection against tuberculosis and suggest that higher levels of DC-SIGN may be beneficial in protection against tuberculosis disease.
###end p 41
###begin p 42
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 424 432 424 432 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S1</bold>
###xml 424 432 424 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001388.s001"><bold>Table S1</bold></xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Barreiro2">[30]</xref>
###xml 670 678 670 678 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 670 678 670 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001388-g002"><bold>Figure 2</bold></xref>
###xml 1070 1071 1070 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1386 1391 1386 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 315 320 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 393 398 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Here we report studies of the CD209 -336A/G SNP in multiple tuberculosis case control groups based in The Gambia, Republic of Guinea, Guinea-Bissau, and Malawi. These studies, taken together, reveal a genetic association with the -336G allele and protection against tuberculosis. This protection was independent of HIV-1 status as assessed by logistic regression as well as removing all known HIV-1 cases from the analysis (Table S1). These results differ from the Barrerio study [30]. This discrepancy could reflect a chance finding in the original single study group, since the confidence interval for this population overlaps with those of our three smaller studies (Figure 2). Barreiro and colleagues studied a South African Coloured population known to have the -871 variant, which was absent in all of the sub-Saharan African populations previously genotyped and very rare (<2.5%) in this study. Indeed, it was the -871 variant which showed the most compelling evidence of association, with the -336 variant failing to reach even the nominal significance level of P = 0.05 after correcting for multiple testing. Due to the relative absence of the -871 variant in the African populations genotyped in this present study we could not ascertain the effect of this variant in susceptibility to tuberculosis and it is entirely possible that the -871/-336 haplotype drives differential CD209 expression patterns but further work will be needed to confirm this.
###end p 42
###begin title 43
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
Odds ratio plot (with 95% confidence intervals) for CD209 -336A/G.
###end title 43
###begin p 44
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
The odds ratio (with 95% confidence intervals) for CD209 -336A/G for each of the studies are shown. Studies include the Barreiro study (ref. 30), The Gambia (A) (ref. 33), The Gambia (B) (ref. 34), Republic of Guinea (ref. 33), Guinea-Bissau (ref. 33) and Malawi (ref. 35). The central mark on each line indicates the odds ratio for each study and the line indicates that 95% confidence interval for each. The dashed line indicates the extent of the 95% confidence interval for the combined analysis of the populations analyzed for this study.
###end p 44
###begin p 45
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Condos1">[38]</xref>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-vanCrevel1">[40]</xref>
###xml 994 998 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Geijtenbeek4">[22]</xref>
###xml 1000 1004 1000 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-vanKooyk2">[29]</xref>
###xml 1006 1010 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Soilleux2">[41]</xref>
###xml 1012 1016 1012 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Soilleux3">[42]</xref>
Subgroup analysis suggested a significant association between CD209 -336GG genotype status and protection against lung cavitation. The potential role of DC-SIGN in cavitory tuberculosis disease is novel and warrants further investigation. In this study we are not able to distinguish between cavitory tuberculosis caused by progression from primary infection, re-infection, or indeed by canonical post-primary reactivation disease. Cavitory tuberculosis in this setting defines a particularly severe manifestation of tuberculosis. Pulmonary cavitation in tuberculosis is known to be associated with the production of Th2 cytokines such as IL-4, which have in turn been demonstrated to result in higher surface expression levels of DC-SIGN in DCs [38]-[40]. This raises the interesting question of whether individuals homozygous for the -336G allele may, in part, be protected from expressing high levels of DC-SIGN and therefore less prone to the Th2 shift induced by ManLam binding to DC-SIGN [22], [29], [41], [42].
###end p 45
###begin p 46
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-vanKooyk3">[43]</xref>
###xml 527 545 527 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium spp.</italic>
###xml 786 790 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001388-Torrelles1">[44]</xref>
###xml 883 898 877 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 883 898 <span type="species:ncbi:1773">M. tuberculosis</span>
Maturation of DCs, defined by DC upregulation of co-stimulatory molecules such as CD80/CD86, can occur on exposure to TLR ligands. This process can however be inhibited by a variety of unknown mechanisms. One possible mechanism of inhibition of DC maturation is the binding of pattern recognition receptors to molecular patterns present on host cells [43]. This process, in theory, would cause DC anergy and a reduction in the pro-inflammatory response, even in the presence of pathogen-associated molecular patterns. Virulent Mycobacterium spp. have evolved mechanisms to more heavily decorate the cell wall lipoglycoconjugates with alpha(1-->2) mannosylated termini which closely resemble the high mannose N-linked oligosaccharides of newly produced glycoproteins in eukaryotic cells [44]. Perhaps this molecular mimicry could be part of the mechanism by which virulent strains of M. tuberculosis modulate the immune response. If so, DC-SIGN is a prime target for this virulence strategy.
###end p 46
###begin p 47
###xml 374 389 374 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 374 389 <span type="species:ncbi:1773">M. tuberculosis</span>
Overall, our results suggest that lower levels of DC-SIGN on immune subsets may be protective against tuberculosis in the sub-Saharan Africa setting. The findings implicate the involvement of DC-SIGN in the pathogenesis of clinical tuberculosis in general, and severe, cavitory tuberculosis in particular. This has wider implications since it provides further evidence that M. tuberculosis may use the DC-SIGN receptor to subvert the immune response.
###end p 47
###begin title 48
Supporting Information
###end title 48
###begin p 49
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD209</italic>
###xml 135 136 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 88 93 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 147 152 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CD209-336A/G SNP Allelic Association in Tuberculosis Case Control Studies Excluding All HIV-1 Positive Cases and Controls. The allelic P value for HIV-1 negative individuals enrolled in tuberculosis case control studies. The Gambia (A), Republic of Guinea and Guinea-Bissau (ref. 33), The Gambia (B) (ref. 34) and Malawi (ref. 35). *The Gambia (B) study utilizes The Gambia (A) controls. Significance levels of P<0.05 are indicated in bold.
###end p 49
###begin p 50
(0.06 MB DOC)
###end p 50
###begin p 51
Click here for additional data file.
###end p 51
###begin title 52
References
###end title 52
###begin article-title 53
WHO annual report on global TB control-summary.
###end article-title 53
###begin article-title 54
Tuberculosis.
###end article-title 54
###begin article-title 55
Immunology of tuberculosis.
###end article-title 55
###begin article-title 56
###xml 30 35 <span type="species:ncbi:9606">human</span>
Genetics of susceptibility to human infectious disease.
###end article-title 56
###begin article-title 57
Tuberculosis in twins: a re-analysis of the Prophit survey.
###end article-title 57
###begin article-title 58
###xml 53 79 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Racial differences in susceptibility to infection by Mycobacterium tuberculosis.
###end article-title 58
###begin article-title 59
Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update.
###end article-title 59
###begin article-title 60
DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13.
###end article-title 60
###begin article-title 61
###xml 99 107 <span type="species:ncbi:9606">patients</span>
DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis.
###end article-title 61
###begin article-title 62
###xml 21 47 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 60 65 <span type="species:ncbi:9606">human</span>
DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells.
###end article-title 62
###begin article-title 63
Pattern recognition receptors: doubling up for the innate immune response.
###end article-title 63
###begin article-title 64
DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.
###end article-title 64
###begin article-title 65
Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.
###end article-title 65
###begin article-title 66
###xml 68 94 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
How is the phagocyte lectin keyboard played? Master class lesson by Mycobacterium tuberculosis.
###end article-title 66
###begin article-title 67
###xml 20 46 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance.
###end article-title 67
###begin article-title 68
###xml 60 71 <span type="species:ncbi:205488">Ebola virus</span>
C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.
###end article-title 68
###begin article-title 69
Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells.
###end article-title 69
###begin article-title 70
###xml 23 43 <span type="species:ncbi:1769">Mycobacterium leprae</span>
DC-SIGN interacts with Mycobacterium leprae but sequence variation in this lectin is not associated with leprosy in the Pakistani population.
###end article-title 70
###begin article-title 71
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN.
###end article-title 71
###begin article-title 72
###xml 138 143 <span type="species:ncbi:9606">human</span>
Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes.
###end article-title 72
###begin article-title 73
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.
###end article-title 73
###begin article-title 74
Mycobacteria target DC-SIGN to suppress dendritic cell function.
###end article-title 74
###begin article-title 75
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection.
###end article-title 75
###begin article-title 76
Identification of the mycobacterial carbohydrate structure that binds the C-type lectins DC-SIGN, L-SIGN and SIGNR1.
###end article-title 76
###begin article-title 77
###xml 66 83 <span type="species:ncbi:11103">hepatitis C virus</span>
C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.
###end article-title 77
###begin article-title 78
###xml 71 76 <span type="species:ncbi:9606">human</span>
DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans.
###end article-title 78
###begin article-title 79
###xml 0 17 <span type="species:ncbi:11103">Hepatitis C virus</span>
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR.
###end article-title 79
###begin article-title 80
###xml 25 37 <span type="species:ncbi:12637">dengue virus</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells.
###end article-title 80
###begin article-title 81
DC-SIGN: escape mechanism for pathogens.
###end article-title 81
###begin article-title 82
Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis.
###end article-title 82
###begin article-title 83
###xml 113 148 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection.
###end article-title 83
###begin article-title 84
A variant in the CD209 promoter is associated with severity of dengue disease.
###end article-title 84
###begin article-title 85
Investigation of environmental and host-related risk factors for tuberculosis in Africa. II. Investigation of host genetic factors.
###end article-title 85
###begin article-title 86
Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans.
###end article-title 86
###begin article-title 87
Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi.
###end article-title 87
###begin article-title 88
MALDI-TOF mass spectrometry-based SNP genotyping.
###end article-title 88
###begin article-title 89
Investigation of environmental and host-related risk factors for tuberculosis in Africa. I. Methodological aspects of a combined design.
###end article-title 89
###begin article-title 90
Local immune responses correlate with presentation and outcome in tuberculosis.
###end article-title 90
###begin article-title 91
T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis.
###end article-title 91
###begin article-title 92
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities.
###end article-title 92
###begin article-title 93
Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro.
###end article-title 93
###begin article-title 94
DC-SIGN association with the Th2 environment of lepromatous lesions: cause or effect?
###end article-title 94
###begin article-title 95
Pathogens use carbohydrates to escape immunity induced by dendritic cells.
###end article-title 95
###begin article-title 96
###xml 106 132 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors.
###end article-title 96
###begin p 97
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 97
###begin p 98
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: FOV is supported by the EU GenoSept Grant and the UK Overseas Research Student Scheme. SJC is a Wellcome Trust Clinical Research Fellow; AVSH is a Wellcome Trust Principal Fellow. CCK is a scholar of the Agency for Science, Technology and Research (A-STAR), Singapore and member of the MBBS-PhD programme, Faculty of Medicine, National University of Singapore. The tuberculosis samples were collected as part of an EU-funded project (contract number IC18CT980375). This work was funded by the Wellcome Trust.
###end p 98

